Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease

被引:38
作者
Leung, R [1 ]
Hill, P [1 ]
Burdon, J [1 ]
机构
[1] ST VINCENTS HOSP,DEPT RESP MED,FITZROY,VIC 3065,AUSTRALIA
关键词
inhaled morphine; exercise endurance; breathlessness;
D O I
10.1136/thx.51.6.596
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Inhaled morphine has previously been shown to increase exercise endurance in patients with chronic lung disease. A similar study was performed to determine whether inhaled morphine reduces the sensation of breathlessness in this group of patients. Methods - A randomised double blind study on the effect of nebulised morphine on both exercise induced breathlessness and maximum achievable power output using isotonic saline as a control was performed in 10 patients with stable chronic lung disease. Each subject performed a progressive exercise test (Jones' stage I) on an electrically braked cycle ergometer. The work load was increased by 10 watts per minute and subjects exercised to exhaustion. At the end of each minute of exercise patients were asked to rate their degree of breathlessness according to a modified Borg scale. All subjects were randomised to receive either inhaled morphine sulphate 1 mg/ml (5 mi) or isotonic (5 ml) by wet nebulisation. The of morphine and saline on the achieved exercise capacity and the development of breathlessness during exercise was tested on separate days. Results - The mean dose of morphine inhaled was 1.24 mg. There was no difference in maximum power output achieved, minute ventilation at maximum power output, nor the degree of breathlessness at maximum power output between the groups treated with morphine and placebo. The degree of breathlessness was related to the power output achieved during exercise by a power function relationship (mean r: morphine = 0.86, saline = 0.87). However, there was a wide variation in the sensation for any given power output in both groups. There was no difference in the group mean slopes (morphine = 1.15, saline = 1.00) or intercepts (morphine = 0.07, saline = 0.15) in this relationship between the morphine and saline treatment groups. Conclusions - In patients with severe chronic lung disease inhaled morphine in the doses used in this study does not relieve exercise induced breathlessness nor does it increase maximum power output achieved during progressive exercise.
引用
收藏
页码:596 / 600
页数:5
相关论文
共 21 条
[1]  
BORG G, 1978, SCAND J REHABIL ME S, V6, P108
[2]   EXPRESSION OF OPIOID-PEPTIDES IN TUMORS [J].
BOSTWICK, DG ;
NULL, WE ;
HOLMES, D ;
WEBER, E ;
BARCHAS, JD ;
BENSCH, KG .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (23) :1439-1443
[3]   CHRONIC LUNG-DISEASE AND THE PERCEPTION OF BREATHLESSNESS - A CLINICAL PERSPECTIVE [J].
BURDON, JGW ;
PAIN, MCF ;
RUBINFELD, AR ;
NANA, A .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (07) :1342-1349
[4]  
BURNS BH, 1969, Q J MED, V38, P277
[5]  
EISER N, 1991, EUR RESPIR J, V4, P926
[6]   DIHYDROCODEINE FOR BREATHLESSNESS IN PINK PUFFERS [J].
JOHNSON, MA ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1983, 286 (6366) :675-677
[7]  
Jones NL., 1982, Clinical exercise testing, V2nd edn
[8]  
KILLIAN KJ, 1985, THORAX, V29, P787
[9]   EFFECTS OF ORAL MORPHINE ON BREATHLESSNESS AND EXERCISE TOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
LIGHT, RW ;
MURO, JR ;
SATO, RI ;
STANSBURY, DW ;
FISCHER, CE ;
BROWN, SE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (01) :126-133
[10]   EFFECT OF ALPRAZOLAM ON EXERCISE AND DYSPNEA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
MAN, GCW ;
HSU, K ;
SPROULE, BJ .
CHEST, 1986, 90 (06) :832-836